ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1638

Comparison and Assessment of the All of Us Dataset for Epidemiologic Studies of Systemic Lupus Erythematosus (SLE) Among African American Women

Katherine Singleton1, Sarah Smith2, Charmayne Dunlop-Thomas3, L. Quinnette King2, Lori Ann Ueberroth4, Edith Williams5, S. Sam Lim6, Bethany Wolf2, Diane Kamen7 and Paula Ramos6, 1Emory University School of Medicine, Atlants, GA, 2Medical University of South Carolina, Charleston, SC, 3Emory University, Atlanta, GA, 4Medical University of South Carolina, Charleston, 5University of Rochester Medical Center, Rochester, NY, 6Emory University School of Medicine, Atlanta, GA, 7Medical University of South Carolina, Johns Island, SC

Meeting: ACR Convergence 2025

Keywords: Epidemiology, population studies, Social support, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1633–1649) ARP Posters II: ARP Epidemiology & Public Health

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose:
Health disparities in SLE are well established, with African American women being disproportionately impacted. Despite the known associations between sociodemographic and genetic factors with SLE, there is limited research into epidemiologic factors and research integrating molecular and epidemiologic data to understand the combined role of these factors in SLE disparities. The All of Us Research Program is collecting both genetic and epidemiologic data, thus promises to be a valuable resource to close this research gap. However, its reliance on volunteer participants may introduce biases that compromise the external validity of epidemiological studies. The goal of this study is to compare sociodemographic data from African American women with SLE between the nation-wide All of Us (AoU) and our research population from coastal South Carolina, to assess whether sociodemographic differences exist between these studies.

Methods:
Our study population consists of 138 African American women meeting either the 1997 ACR revised criteria or the SLICC criteria for SLE who have been recruited in our ongoing Social Factors, Epigenomics, and Lupus in African American women (SELA) study. The All of Us (AoU) dataset includes self-report questionnaire data from 633,540 participants, of which 309 are African American women diagnosed with SLE (identified by ICD-9 710.0 or ICD-10 M32 codes (excluding M32.0)) who have completed “The Basics,” “Lifestyle,” and “Social Factors of Health” surveys. We subset these individuals and compared their survey responses to those asked in the SELA study, including sociodemographic data and questions aligning with the Medical Outcomes Study Social Support Survey (MOS-SS). MOS-SS scores between the two groups were analyzed using a Wilcoxon rank-sum test. Sociodemographic data was analyzed using a series of Chi-squared tests.

Results:
The African American women with SLE in the AoU dataset demonstrate less social support than those of the SELA dataset (p = 0.0022). They are more likely to have been divorced, widowed, or separated (p = 0.0034) or single (p = 0.0013) as opposed to married. The women in the SELA cohort are more likely to be employed (p = 0.0005) than the AoU cohort, and the AoU cohort has a higher proportion of participants that are under the federal poverty line (p = 0.0033). However, the proportion of total participants defined as low income (under 200% of the federal poverty line) does not differ significantly between the two cohorts. The women in the AoU cohort are more likely to have a history of smoking (p = 0.0025) but show no significant difference in binge drinking behavior with the SELA cohort.

Conclusion:
Our study may suggest key differences between these two datasets in terms of social support and sociodemographics that researchers should be aware of before using these datasets for further genomic and epidemiological research. These results reflect the social, economic, and behavioral diversity of populations with SLE. Awareness and inclusion of these diverse populations in research is paramount to the development of precision public health strategies to close the health disparities gap.


Disclosures: K. Singleton: None; S. Smith: None; C. Dunlop-Thomas: None; L. King: None; L. Ueberroth: None; E. Williams: None; S. Lim: Accordant, 2, AstraZeneca, 2, Biogen, 5, BMS, 5, Genentech, 2, Gilead, 5, GSK, 2, Novartis, 5, UCB, 5; B. Wolf: None; D. Kamen: None; P. Ramos: None.

To cite this abstract in AMA style:

Singleton K, Smith S, Dunlop-Thomas C, King L, Ueberroth L, Williams E, Lim S, Wolf B, Kamen D, Ramos P. Comparison and Assessment of the All of Us Dataset for Epidemiologic Studies of Systemic Lupus Erythematosus (SLE) Among African American Women [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/comparison-and-assessment-of-the-all-of-us-dataset-for-epidemiologic-studies-of-systemic-lupus-erythematosus-sle-among-african-american-women/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-and-assessment-of-the-all-of-us-dataset-for-epidemiologic-studies-of-systemic-lupus-erythematosus-sle-among-african-american-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology